The guideline for “Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer” is in the process of being finalized, with expected release for Summer 2009.
Topics detailed in the guideline include:
Clinical practice recommendations and evidence
The role of SLNB in specific clinical circumstances
Factors that affect the success of SLNB
Potential harms and benefits
Technical aspects SLNB
Organization of care recommendations
The guideline has been developed in partnership with the Program in Evidence Based Care and an Expert panel, led by Dr. Ralph George and its members of experts in breast surgery, pathologists and nuclear medicine.